JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (2007) 193, 435-444    DOI: 10.1677/JOE-07-0099
© 2007 Society for Endocrinology

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wagner, M. S
Right arrow Articles by Maia, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wagner, M. S
Right arrow Articles by Maia, A. L.

Regulation of Dio2 gene expression by thyroid hormones in normal and type 1 deiodinase-deficient C3H mice

Marcia S Wagner, Simone M Wajner, José M Dora and Ana Luiza Maia

Endocrine Division, Thyroid Section, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, 2350, 90035-003 Porto Alegre, Rio Grande do Sul, Brazil

(Requests for offprints should be addressed to A L Maia; Email: almaia{at}ufrgs.br)

The C3H/HeJ mouse presents an inherited type 1 deiodinase (D1) deficiency that results in elevated serum thyroxine (T4), whereas TSH and tri-iodothyronine (T3) concentrations are normal when compared with those in the C57BL/6J strain. Here, we evaluated the expression of the type 2 (D2), the other T4-activating enzyme, in C3H mice. A comparative analysis revealed that D2 mRNA levels in C3H are similar to those in C57 animals. The D2 activity in C3H pituitary and brain are reduced when compared with those in the C57 strain (3.75 ± 1.08 vs 5.78 ± 0.33 and 0.17 ± 0.05 vs 0.26 ± 0.07 fmol/min per mg protein respectively). However, no differences on D2 activity levels were observed in the brown adipose tissue (BAT) between both strains (0.34 ± 0.06 vs 0.36 ± 0.09 fmol/min per mg protein). Experiments using different T4 doses showed that higher levels of serum T4 than those of the C3H mouse are required to downregulate D2 activity in this tissue. T3 administration to euthyroid mice resulted in a two- to four-fold increase on D2 activity in BAT and brain of both strains, despite a marked decrease in BAT D2 transcripts and no changes in brain D2 mRNA levels. The increase in D2 activity was preceded by a decrease in serum T4 levels, which appears to reduce D2 degradation. Indeed, administration of T3 plus T4 abolished the T3-induced D2 upregulation. In conclusion, our results demonstrated that D2 activity is mainly regulated at posttranslational level in a tissue-specific manner. These observations further characterize and provide insights into the complex and dual regulatory role of the iodothyronines in D2 regulation.







HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Society for Endocrinology.